Why Tesla Stock Was Pulling Back Today

The Motley Fool
Updated
Mitrade
coverImg
Source: Shutterstock

After a dramatic bull run following the election of Donald Trump last week, Tesla (NASDAQ: TSLA) shares are finally cooling off today, pulling back in line with a broader sell-off as the S&P 500 is headed for its first decline since the election.

There was no major company-specific news out on Tesla, though Hertz Global again offered evidence that demand for electric vehicles (EVs) isn't as strong as bulls have hoped. Investors appear to be questioning the valuation after the stock jumped nearly 40% over the four sessions after the election.

As of 2:56 p.m. ET, the stock was down 5%.

A Tesla Model 3 on a snowy road.

Image source: Tesla.

Tesla runs out of gas

The only piece of news that would have directly weighed on the stock was Hertz's announcement that it continues to see weak demand for EVs and will sell 30,000 of them by the end of the year. Relatedly, J.D. Power projected that EVs coming off leases would also flood the market in the next two years, hitting 65,600 by the end of this year and 215,000 by 2026.

However, the main reason for today's sell-off seemed to be related to sentiment and valuation as Tesla's surge has come without any clear benefit to the business, and with the broader pullback in the market, investors seem to be saying the post-election rally has run out of steam.

Is Tesla a buy?

Tesla has soared in the aftermath of the election as CEO Elon Musk closely aligned himself with Trump, but it's not fully clear that getting in the president's good graces is going to benefit his EV company.

After all, Trump campaigned on a plan to eliminate the tax credit for EVs and other clean energy programs, and Musk himself has complained that affordability is one of the biggest factors preventing Tesla and EVs more broadly from gaining more market share. Losing the credit, which is worth as much as $7,500 on some of Tesla's vehicles, would seem to be a clear negative for the company.

Investors are ultimately hopeful that the Trump administration will loosen up rules around autonomy, making it easier for Tesla to roll out its new robotaxi, or Cybercab, but safety and public perception will be the most critical test for the vehicles. If they cause accidents and Tesla is perceived as getting special favors from the government, that would likely be a disaster for its reputation.

There's still a lot of uncertainty for the company despite Musk's cozy relationship with Trump, and the stock trades at a demanding multiple. If the Trump-related thesis doesn't work out, Tesla stock could have a long way to fall.

* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
India’s economy is tumbling, and it might take whole world down with itIndia’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
Author  Cryptopolitan
12 hours ago
India’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
placeholder
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
Author  The Motley Fool
12 hours ago
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
placeholder
Novo Nordisk Sees Retail Buying Despite Wall Street CutsShares of leading weight-loss drugmaker Novo Nordisk (NVO.US) plunged after disappointing results from its latest weight-loss drug trial. Despite analysts slashing their price targets, retail investors flooded into the stock with massive buy-the-dip activity.
Author  Mitrade
17 hours ago
Shares of leading weight-loss drugmaker Novo Nordisk (NVO.US) plunged after disappointing results from its latest weight-loss drug trial. Despite analysts slashing their price targets, retail investors flooded into the stock with massive buy-the-dip activity.
placeholder
The Year of Concentration, Crypto, ChinaWhy 2024 was such a good year for investors, and the concerns they have about valuations and market concentration as they look ahead to 2025.
Author  The Motley Fool
19 hours ago
Why 2024 was such a good year for investors, and the concerns they have about valuations and market concentration as they look ahead to 2025.
placeholder
Prediction: This Energy Stock Will Deliver Substantial Market-Beating ReturnsExplore the exciting world of Chart Industries (NYSE: GTLS) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Author  The Motley Fool
19 hours ago
Explore the exciting world of Chart Industries (NYSE: GTLS) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!